[Preliminary Study on the Characteristic of Plasma Cytokine Profiles in Patients with Idiopathic Multicentric Castleman Diseases]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Aug;27(4):1305-1310. doi: 10.19746/j.cnki.issn.1009-2137.2019.04.051.
[Article in Chinese]

Abstract

Objective: To investigate the characteristic changes of the plasma cytokine profile in Chinese patients with idiopathic multicentric Castleman diseases (iMCD).

Methods: The plasma samples from 22 patients with confirmed diagnosis of iMCD were collected before treatments; Specimens from 17 patients with newly diagnosed multiple myeloma, 10 non Hodgkin's lymphoma, and 15 healthy donors were used as control. Seventeen kinds of cytokines were measured by cytokine beads array (CBA) and ELISA respectively.

Results: Six cytokines were measured by ELISA. The concentrations of IL-2, IL-6, IL-21 and VEGF were significantly higher in the plasma of iMCD patients than those of the healthy donors (P<0.01) and the level of IL-21 was highest in the iMCD group. There was no significant difference in the levels of IL-1β and IL-4 between the iMCD and healthy donor groups. Thirteen cytokines were measured by CBA assay, besides IL-6 level was confirmed to be higher in iMCD group than that in healthy controls (P<0.01), IL-12-p70 and IL-33 levels were also higher in iMCD group than those in control group (P<0.05), no significant difference of the rest cytokines was found between iMCD and the control group.

Conclusion: IL-6 and VEGF has shown to involved in the pathogenesis of iMCD, the results of preliminary study imply the role of IL-2 、IL-21、IL-12-p70 and IL-33 in this rare lymphoproliferative disease. Further studies are needed to elucidate the mechanism of these cytokines, which may shed some light on the identification of novel therapeutic targets against iMCD.

题目: 特发性多中心型Castleman病患者细胞因子谱特征的初步分析.

目的: 研究我国特发性多中心型Castleman病(idiopathic multicentric castleman disease,iMCD)患者血浆中细胞因子谱的特征性改变.

方法: 收集22例确诊iMCD患者治疗前的血浆标本,并以17例初发多发性骨髓瘤(MM)、10例非霍奇金淋巴瘤(NHL)及15例健康供者血浆标本作为对照,应用细胞因子磁珠阵列(cytokine beads array,CBA)和ELISA 2种方法,检测17种细胞因子的浓度.

结果: ELISA法检测的6种细胞因子中,iMCD患者的IL-2,IL-6,IL-21和VEGF的血浆水平均明显高于正常对照( P<0.01),且IL-21水平在iMCD组最高;IL-1β和IL-4水平与正常对照无差异。CBA法检测13种细胞因子浓度结果显示,iMCD患者的IL-6、IL-33和IL-12-p70水平均明显高于正常对照(P<0.01),其余细胞因子与正常对照相比均无显著差异(P> 0.05).

结论: 除了已知的IL-6和VEGF可能参与了iMCD的发生发展外,IL-2 、IL-21、IL-12-p70和IL-33的作用值得进一步探讨,相关研究可能发现iMCD治疗的新型靶点.

MeSH terms

  • Castleman Disease*
  • Cytokines
  • Humans
  • Interleukin-12
  • Interleukin-1beta
  • Plasma

Substances

  • Cytokines
  • Interleukin-1beta
  • Interleukin-12